Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiency Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03405194
What this trial is testing

Same-Day Treatment With Genvoya vs. EFV/TDF/3TC

Who this might be right for
HIV/AIDS
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Testing effectiveness (Phase 2)Study completedNCT00885495
What this trial is testing

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

Who this might be right for
HIV Infections
University of Cincinnati 17
Not applicableActive Not RecruitingNCT05965245
What this trial is testing

Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Who this might be right for
DepressionHIV Infection
Washington University School of Medicine 248
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Post-approval studies (Phase 4)Study completedNCT00402454
What this trial is testing

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Who this might be right for
HIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 300
Large-scale testing (Phase 3)Study completedNCT00421551
What this trial is testing

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 225
Not applicableStudy completedNCT00002029
What this trial is testing

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

Who this might be right for
HIV Infections
Abbott
Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Not applicableUnknownNCT00951886
What this trial is testing

The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally

Who this might be right for
Ataxia Telangiectasia
Sheba Medical Center 28
Not applicableStudy completedNCT00696839
What this trial is testing

Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects

Who this might be right for
HIV InfectionsAdverse Effects
Duquesne University 29
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT00000739
What this trial is testing

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Not applicableStudy completedNCT01671501
What this trial is testing

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

Who this might be right for
HIVAcquired Immunodeficiency SyndromeAlcoholism+2 more
University of California, San Francisco 614
Not applicableUnknownNCT00974519
What this trial is testing

The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients

Who this might be right for
Acquired Immune Deficiency Syndrome VirusHIV Infections
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 180
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Early research (Phase 1)Study completedNCT00002111
What this trial is testing

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Who this might be right for
HIV Infections
Stanford University 32
Not applicableStudy completedNCT00618371
What this trial is testing

Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia

Who this might be right for
HIV Infection
University of Pittsburgh 10
Next Page